title: Flow-mediated dilation: can new approaches provide greater mechanistic insight into vascular dysfunction in preeclampsia and other diseases?
abstract: Endothelial dysfunction is a key feature of preeclampsia and may contribute to increased cardiovascular disease risk years after pregnancy. Flow-mediated dilation (FMD) is a non-invasive endothelial function test that predicts cardiovascular event risk. New protocols allow researchers to measure three components of the FMD response: FMD, low flow-mediated constriction, and shear stimulus. This review encourages researchers to think beyond "low FMD" by examining how these three components may provide additional insights into the mechanisms and location of vascular dysfunction. The review then examines what FMD studies reveal about vascular dysfunction in preeclampsia while highlighting opportunities to gain greater mechanistic insight from new protocols. Studies using traditional protocols show that FMD is low in mid-pregnancy prior to preeclampsia, at diagnosis, and for 3 years post-partum. However, FMD returns to normal by 10 years post-partum. Studies using new protocols are needed to gain more mechanistic insight.
authors.affiliation: Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street SW, RO-HA-06-675B-5, Rochester, MN, 55905, USA, weissgerber.tracey@mayo.edu.
authors.forename: Tracey L
authors.initials: TL
authors.lastname: Weissgerber
mesh_terms: D001916:Brachial Artery / Q000503:physiopathology*; D004730:Endothelium, Vascular / Q000503:physiopathology*; D005260:Female; D005820:Genetic Testing; D006801:Humans; D006973:Hypertension / Q000503:physiopathology*; D011225:Pre-Eclampsia / Q000503:physiopathology* / Q000628:therapy; D011247:Pregnancy; D014652:Vascular Diseases / Q000503:physiopathology*